FDA warning letter · Drugs

Centrient Pharmaceuticals India Private Limited

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Failure of your quality unit to exercise its responsibility to ensure the API manufactured at your facility are in compliance with CGMP.

Passage 2

Failure to ensure that all test procedures are scientifically sound and appropriate to ensure that your API conform to established standards of quality and purity.

Passage 3

Failure to establish and follow written procedures for investigating critical deviations or the failure of API batches to meet specifications.